TTYH3 is a Prognostic Biomarker and Associates with Immune Cell Infiltrations of Lung Adenocarcinoma

Tweet about this on TwitterShare on FacebookEmail this to someoneShare on Google+

Jian Xu; Jiming Chen; Honglu Duan; Dandan Zhang; Yilu Li; Xiaoni Xu & Xiaoli Li


We investigated Tweety Family Member 3 (TTYH3) level in lung adenocarcinoma (LUAD) and its relationship with immune infiltration in tumors by bioinformatics. Differential expressions of TTYH3 in lung cancer were analyzed with Oncomine, TIMER, GEO, UALCAN and HPA. Relationship of TTYH3 mRNA/protein levels with clinical parameters was analyzed by UALCAN. Co-expressed genes of TTYH3 in LUAD were analyzed using Cbioportal. Its relationship with LUAD prognosis was analyzed by Kaplan–Meier plotter. GO and KEGG analysis were performed. Correlation between TTYH3 and tumor immune infiltration were tested by TIMER, TISIDB and GEPIA. We found that TTYH3 was significantly increased in LUAD tissues. TTYH3 high expression was closely related to poor overall survival, post progression survival and first progression in LUAD patients. TTYH3 mRNA/protein levels were significantly associated with multiple pathways. Specifically, TTYH3 up-regulation was mostly related to biological regulation, metabolic process, protein blinding, extracellular matrix organization and pathways in cancer. Moreover, TTYH3 was positively associated with immune cell infiltration in LUAD. Finally, TTYH3 was highly expressed in LUAD as revealed by meta-analysis. TTYH3 is closely related to the prognosis of LUAD and immune cell infiltration, and it can be used as a prognostic biomarker for LUAD and immune infiltration.

KEY WORDS: TTYH3; Immune infiltration; Lymphocytes; Prognosis; Lung adenocarcinoma (LUAD).

How to cite this article

XU, J.; CHEN, J.; DUAN, H.; ZHANG, D.; LI, Y.; XU, X. & LI, X. TTYH3 is a prognostic biomarker and associates with immune cell infiltrations of lung adenocarcinoma. Int. J. Morphol., 41(1):118-133, 2023.